<p>梅萨实验室（NASDAQ:MLAB - 获取免费报告）在周一发布的报告中被 Zacks Research 的投资分析师从 “强烈卖出” 评级上调至 “持有” 评级，Zacks.com 报道。</p>
<p>MLAB 还受到其他几份研究报告的关注。华尔街 Zen 在 8 月 9 日的研究报告中将梅萨实验室的股票评级从 “买入” 下调至 “持有”。富国银行在 8 月 7 日的研究报告中将梅萨实验室的股票评级从 “减持” 上调至 “持平”，并将该股票的目标价格从 100.00 美元下调至 67.00 美元。一位研究分析师对该股票给予了买入评级，另外两位给予了持有评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “持有”，平均目标价格为 113.50 美元。</p>
<p>获取 <strong>梅萨实验室</strong> 的提醒：</p>
<p><strong>获取我们关于梅萨实验室的最新股票报告</strong></p>
<h2>梅萨实验室股票表现</h2>
<p>MLAB 股票在周一开盘价为 69.2550 美元。该公司的速动比率为 0.47，流动比率为 0.66，债务与股本比率为 0.46。梅萨实验室的 52 周低点为 55.45 美元，52 周高点为 155.12 美元。该股票的市值为 3.809 亿美元，市盈率为-494.68，贝塔值为 0.83。该公司的 50 日移动平均线为 82.73 美元，200 日移动平均线为 108.85 美元。</p>
<h2>梅萨实验室的内部交易</h2>
<p>在其他新闻中，首席执行官 Gary M. Owens 在 6 月 16 日的交易中出售了 1,939 股公司的股票。股票以平均价格 97.12 美元出售，总交易额为 188,315.68 美元。交易后，首席执行官直接持有公司 45,824 股，价值 4,450,426.88 美元。此次交易使其持股减少了 4.06%。该出售在与 SEC 的法律文件中披露，相关信息可通过此链接获取。此外，首席财务官 John Sakys 在 6 月 16 日的交易中出售了 642 股公司的股票。股票以平均价格 97.12 美元出售，总交易额为 62,351.04 美元。交易后，首席财务官持有公司 12,865 股，价值约 1,249,448.80 美元。此次交易使其持股减少了 4.75%。该出售的披露信息可在此找到。在过去的九十天里，内部人士总共出售了价值 296,507 美元的 3,053 股公司股票。目前，4.90% 的股票由公司内部人士持有。</p>
<h2>机构资金流入和流出</h2>
<p>一些机构投资者和对冲基金最近对该公司的持仓进行了调整。怀俄明州在第一季度将其在梅萨实验室的持股增加了 501.4%。怀俄明州现在拥有 427 股医疗仪器供应商的股票，价值 51,000 美元，此前在上个季度购买了 356 股。Quantbot Technologies LP 在第一季度购买了梅萨实验室的新股份，价值约 67,000 美元。法国巴黎银行金融市场在第二季度将其在梅萨实验室的持股增加了 115.3%。法国巴黎银行金融市场现在拥有 786 股医疗仪器供应商的股票，价值 74,000 美元，此前在上个季度购买了 421 股。Tower Research Capital LLC TRC 在第二季度将其在梅萨实验室的持股增加了 432.9%。Tower Research Capital LLC TRC 现在拥有 842 股医疗仪器供应商的股票，价值 79,000 美元，此前在上个季度购买了 684 股。最后，US Bancorp DE 在第一季度将其在梅萨实验室的持股增加了 48.3%。US Bancorp DE 现在拥有 1,323 股医疗仪器供应商的股票，价值 157,000 美元，此前在上个季度购买了 431 股。目前，90.60% 的股票由机构投资者和对冲基金持有。</p>
<h2>梅萨实验室公司简介</h2>
<p>（获取免费报告）</p>
<p>梅萨实验室公司在北美、欧洲、亚太地区及国际上开发、设计、制造、销售和服务生命科学工具及质量控制产品和服务。灭菌和消毒控制部门提供生物、化学和清洁指示剂，用于评估制药、医疗器械和医疗行业中灭菌、去污、消毒和清洁过程的有效性。</p>
<h2>特色文章</h2>
<ul>
<li>我们更看好的五只股票比梅萨实验室更好</li>
<li>FTSE 100 指数是什么？</li>
<li>现在支持英特尔复苏的两个强大力量</li>
<li>初学者如何阅读股票图表</li>
<li>阿彻的飞行里程碑和防御胜利让华尔街兴奋</li>
<li>什么是财报？</li>
<li>Upstart 股票可能会因短期挤压而上涨</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在梅萨实验室吗？</h2>
<p>在你考虑梅萨实验室之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买...而梅萨实验室并不在名单上。</p>
<p>虽然梅萨实验室目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

MLAB

<p>Zacks Research 将 Mesa Laboratories (NASDAQ:MLAB) 的评级从 “强烈卖出” 上调至 “持有”。其他分析师也调整了他们的评级，Wall Street Zen 将评级从 “买入” 下调至 “持有”，而富国银行将其目标价从 100 美元下调至 67 美元。目前，MLAB 的平均评级为 “持有”，目标价为 113.50 美元。该股票开盘价为 69.26 美元，市值为 3.809 亿美元。最近有内部人士出售股票的报告，机构持股比例为 90.60%</p>

<p>Mesa Laboratories (NASDAQ:MLAB - Get Free Report) was upgraded by investment analysts at Zacks Research from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a report issued on Monday,Zacks.com reports.</p>
<div class="lb-trans"><p>梅萨实验室（NASDAQ:MLAB - 获取免费报告）在周一发布的报告中被 Zacks Research 的投资分析师从 “强烈卖出” 评级上调至 “持有” 评级，Zacks.com 报道。</p>
</div><p>MLAB has been the subject of several other research reports. Wall Street Zen cut shares of Mesa Laboratories from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research report on Saturday, August 9th. Wells Fargo &amp; Company raised shares of Mesa Laboratories from an &#34;underweight&#34; rating to an &#34;equal weight&#34; rating and decreased their price objective for the stock from $100.00 to $67.00 in a research report on Thursday, August 7th. One research analyst has rated the stock with a Buy rating and two have given a Hold rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of &#34;Hold&#34; and an average target price of $113.50.</p>
<div class="lb-trans"><p>MLAB 还受到其他几份研究报告的关注。华尔街 Zen 在 8 月 9 日的研究报告中将梅萨实验室的股票评级从 “买入” 下调至 “持有”。富国银行在 8 月 7 日的研究报告中将梅萨实验室的股票评级从 “减持” 上调至 “持平”，并将该股票的目标价格从 100.00 美元下调至 67.00 美元。一位研究分析师对该股票给予了买入评级，另外两位给予了持有评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “持有”，平均目标价格为 113.50 美元。</p>
</div><p>Get <strong>Mesa Laboratories</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>梅萨实验室</strong> 的提醒：</p>
</div><p><strong>Get Our Latest Stock Report on Mesa Laboratories</strong></p>
<div class="lb-trans"><p><strong>获取我们关于梅萨实验室的最新股票报告</strong></p>
</div><h2>Mesa Laboratories Stock Performance</h2>
<div class="lb-trans"><h2>梅萨实验室股票表现</h2>
</div><p>Shares of MLAB stock opened at $69.2550 on Monday. The company has a quick ratio of 0.47, a current ratio of 0.66 and a debt-to-equity ratio of 0.46. Mesa Laboratories has a 52 week low of $55.45 and a 52 week high of $155.12. The stock has a market capitalization of $380.90 million, a PE ratio of -494.68 and a beta of 0.83. The firm has a 50 day moving average of $82.73 and a two-hundred day moving average of $108.85.</p>
<div class="lb-trans"><p>MLAB 股票在周一开盘价为 69.2550 美元。该公司的速动比率为 0.47，流动比率为 0.66，债务与股本比率为 0.46。梅萨实验室的 52 周低点为 55.45 美元，52 周高点为 155.12 美元。该股票的市值为 3.809 亿美元，市盈率为-494.68，贝塔值为 0.83。该公司的 50 日移动平均线为 82.73 美元，200 日移动平均线为 108.85 美元。</p>
</div><h2>Insider Transactions at Mesa Laboratories</h2>
<div class="lb-trans"><h2>梅萨实验室的内部交易</h2>
</div><p>In other news, CEO Gary M. Owens sold 1,939 shares of the business's stock in a transaction dated Monday, June 16th. The shares were sold at an average price of $97.12, for a total transaction of $188,315.68. Following the transaction, the chief executive officer directly owned 45,824 shares in the company, valued at $4,450,426.88. The trade was a 4.06% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO John Sakys sold 642 shares of the business's stock in a transaction dated Monday, June 16th. The stock was sold at an average price of $97.12, for a total transaction of $62,351.04. Following the transaction, the chief financial officer owned 12,865 shares in the company, valued at approximately $1,249,448.80. This trade represents a 4.75% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 3,053 shares of company stock worth $296,507 over the last ninety days. 4.90% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在其他新闻中，首席执行官 Gary M. Owens 在 6 月 16 日的交易中出售了 1,939 股公司的股票。股票以平均价格 97.12 美元出售，总交易额为 188,315.68 美元。交易后，首席执行官直接持有公司 45,824 股，价值 4,450,426.88 美元。此次交易使其持股减少了 4.06%。该出售在与 SEC 的法律文件中披露，相关信息可通过此链接获取。此外，首席财务官 John Sakys 在 6 月 16 日的交易中出售了 642 股公司的股票。股票以平均价格 97.12 美元出售，总交易额为 62,351.04 美元。交易后，首席财务官持有公司 12,865 股，价值约 1,249,448.80 美元。此次交易使其持股减少了 4.75%。该出售的披露信息可在此找到。在过去的九十天里，内部人士总共出售了价值 296,507 美元的 3,053 股公司股票。目前，4.90% 的股票由公司内部人士持有。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>A number of institutional investors and hedge funds have recently made changes to their positions in the company. State of Wyoming boosted its holdings in Mesa Laboratories by 501.4% during the first quarter. State of Wyoming now owns 427 shares of the medical instruments supplier's stock worth $51,000 after buying an additional 356 shares in the last quarter. Quantbot Technologies LP purchased a new stake in Mesa Laboratories during the first quarter worth about $67,000. BNP Paribas Financial Markets boosted its holdings in Mesa Laboratories by 115.3% during the second quarter. BNP Paribas Financial Markets now owns 786 shares of the medical instruments supplier's stock worth $74,000 after buying an additional 421 shares in the last quarter. Tower Research Capital LLC TRC boosted its holdings in Mesa Laboratories by 432.9% during the second quarter. Tower Research Capital LLC TRC now owns 842 shares of the medical instruments supplier's stock worth $79,000 after buying an additional 684 shares in the last quarter. Finally, US Bancorp DE boosted its holdings in Mesa Laboratories by 48.3% during the first quarter. US Bancorp DE now owns 1,323 shares of the medical instruments supplier's stock worth $157,000 after buying an additional 431 shares in the last quarter. 90.60% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>一些机构投资者和对冲基金最近对该公司的持仓进行了调整。怀俄明州在第一季度将其在梅萨实验室的持股增加了 501.4%。怀俄明州现在拥有 427 股医疗仪器供应商的股票，价值 51,000 美元，此前在上个季度购买了 356 股。Quantbot Technologies LP 在第一季度购买了梅萨实验室的新股份，价值约 67,000 美元。法国巴黎银行金融市场在第二季度将其在梅萨实验室的持股增加了 115.3%。法国巴黎银行金融市场现在拥有 786 股医疗仪器供应商的股票，价值 74,000 美元，此前在上个季度购买了 421 股。Tower Research Capital LLC TRC 在第二季度将其在梅萨实验室的持股增加了 432.9%。Tower Research Capital LLC TRC 现在拥有 842 股医疗仪器供应商的股票，价值 79,000 美元，此前在上个季度购买了 684 股。最后，US Bancorp DE 在第一季度将其在梅萨实验室的持股增加了 48.3%。US Bancorp DE 现在拥有 1,323 股医疗仪器供应商的股票，价值 157,000 美元，此前在上个季度购买了 431 股。目前，90.60% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Mesa Laboratories Company Profile</h2>
<div class="lb-trans"><h2>梅萨实验室公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.</p>
<div class="lb-trans"><p>梅萨实验室公司在北美、欧洲、亚太地区及国际上开发、设计、制造、销售和服务生命科学工具及质量控制产品和服务。灭菌和消毒控制部门提供生物、化学和清洁指示剂，用于评估制药、医疗器械和医疗行业中灭菌、去污、消毒和清洁过程的有效性。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>特色文章</h2>
</div><ul>
<li>Five stocks we like better than Mesa Laboratories</li>
<li>What is the FTSE 100 index?</li>
<li>2 Powerful Forces Now Back Intel's Turnaround</li>
<li>How to Read Stock Charts for Beginners</li>
<li>Archer's Flight Milestones &amp; Defense Wins Excite Wall Street</li>
<li>What Are Earnings Reports?</li>
<li>Upstart Stock Could Pop on a Short Squeeze Soon</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比梅萨实验室更好</li>
<li>FTSE 100 指数是什么？</li>
<li>现在支持英特尔复苏的两个强大力量</li>
<li>初学者如何阅读股票图表</li>
<li>阿彻的飞行里程碑和防御胜利让华尔街兴奋</li>
<li>什么是财报？</li>
<li>Upstart 股票可能会因短期挤压而上涨</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Mesa Laboratories Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在梅萨实验室吗？</h2>
</div><p>Before you consider Mesa Laboratories, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑梅萨实验室之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mesa Laboratories wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买...而梅萨实验室并不在名单上。</p>
</div><p>While Mesa Laboratories currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然梅萨实验室目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Zacks 研究将 Mesa Laboratories（NASDAQ:MLAB）的评级上调至 “持有”